Insider Transactions

What Anacor Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Rieflin William Jl	Director	Jun 24	Disposition to Issuer · D	−853	$99.25	−$84.7K	0
Rieflin William Jl	Director	Jun 24	Disposition to Issuer · D	−89,000	$99.25	−$8.83M	0
Berns Paul L	President and CEO	Jun 24	Disposition to Issuer · D	−231,311	$99.25	−$23M	0
Leonard Keith R	Director	Jun 24	Disposition to Issuer · D	−794	$99.25	−$78.8K	0
Leschly Mark	Director	Jun 24	Disposition to Issuer · D	−794	$99.25	−$78.8K	0
Sullivan Ryan T	EVP and General Counsel	Jun 24	Disposition to Issuer · D	−30,132	$99.25	−$2.99M	0
Ippolito Vincent P	EVP & Chief Commercial Officer	Jun 24	Disposition to Issuer · D	−68,985	$99.25	−$6.85M	0
Bell Graeme	Executive VP and CFO	Jun 24	Disposition to Issuer · D	−10,488	$99.25	−$1.04M	0
Zane Lee	SVP and Chief Medical Officer	Jun 24	Disposition to Issuer · D	−44,194	$99.25	−$4.39M	0
Wierenga Wendall D	Director	Jun 24	Disposition to Issuer · D	−794	$99.25	−$78.8K	0
Shapiro Lucy	Director	Jun 24	Disposition to Issuer · D	−794	$99.25	−$78.8K	0
Hove Anders D	Director	Jun 24	Disposition to Issuer · D	−33,886	$99.25	−$3.36M	0
Bell Graeme	Executive VP and CFO	Jun 01	Open-market sale · S	−751	$99.28	−$74.6K	10,255
Leonard Keith R	Director	May 23	Open-market sale · S	−9,000	$99.70	−$897K	794
Leonard Keith R	Director	May 23	Exercise / conversion · M	+9,000	$14.22	+$128K	9,794
Hove Anders D	Director	May 16	Disclosed 10b5-1 sale · S	−72,385	$98.93	−$7.16M	0
Hove Anders D	Director	May 16	Disclosed 10b5-1 sale · S	−199,865	$99.41	−$19.9M	72,385
Hove Anders D	Director	May 16	Disclosed 10b5-1 sale · S	−81,631	$100.60	−$8.21M	272,250
Sullivan Ryan T	EVP and General Counsel	Apr 29	Open-market sale · S	−3,125	$66.33	−$207K	30,132
Hove Anders D	Director	Apr 14	Derivative Conversion · C	+257,647	$31.05	+$8M	353,881

Page 1 of 22 · showing the 20 most recent Sign up free to view all 430 transactions and filter by insider →

Comments